Legal aspects of neuroleptic-induced movement disorders.
Wettstein
R M
RM
D017109:Akathisia, Drug-Induced; D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003134:Commitment of Persons with Psychiatric Disorders / Q000331:legislation & jurisprudence; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D005607:Fraud; D006801:Humans; D007258:Informed Consent / Q000331:legislation & jurisprudence; D008318:Malpractice / Q000331:legislation & jurisprudence*; D010302:Parkinson Disease, Secondary / Q000139:chemically induced; D010344:Patient Advocacy / Q000331:legislation & jurisprudence; D010349:Patient Compliance; D010353:Patient Education as Topic / Q000331:legislation & jurisprudence; D011618:Psychotic Disorders / Q000188:drug therapy
D014150:Antipsychotic Agents